Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

Muñóz, Nubia; K. Kjær, Susanne; Sigurðsson, Kristján; Iversen, Ole‐Erik; Hernández‐Ávila, Mauricio; M. Wheeler, Cosette; Pérez, Gonzalo; R. Brown, Darron; A. Koutsky, Laura; Hseon Tay, Eng; García, Patricia; A. Ault, Kevin; M. Garland, Suzanne; Leodolter, Sepp; Olsson, Sven‐Eric; Tang, Grace; G. Ferris, Daron; Paavonen, Jorma; Steben, Marc; Xavier Bosch, F.; Dillner, Joakim; K. Huh, Warner; A. Joura, Elmar; J. Kurman, Robert; Majewski, Sławomir; R. Myers, Evan; L. Villa, Luisa; J. Taddeo, Frank; C. Roberts, Christine; Tadesse, Amha; T. Bryan, Janine; Lupinacci, Lisa; Giacoletti, Katherine; L. Sings, Heather; K. James, Margaret; M. Hesley, Teresa; Barr, Eliav; M. Haupt, Richard

doi:10.1093/jnci/djp534

Public

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

Published in JNCI Journal of the National Cancer Institute • Feb 6, 2010

Authors:

Nubia Muñóz

Susanne K. Kjær

Kristján Sigurðsson

Abstract

BACKGROUND: The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were "negative to 14 HPV types" and in a mixed popu...

Subject

Human papillomavirus

Sex organ

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!